Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

PHASE3RecruitingINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

March 16, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
InfertilityEndometriosis
Interventions
DRUG

Elagolix 200 MG

Elagolix tablet

OTHER

Placebo or SOC IVF

Sugar pill manufactured to mimic Elagolix 200mg

Trial Locations (5)

21205

RECRUITING

Johns Hopkins, Division of Reproductive Science and Women's Health Research, Baltimore

27560

RECRUITING

Duke Fertility, Morrisville

60611

RECRUITING

Northwestern University Department of Obstetrics and Gynecology, Chicago

80045

RECRUITING

University of Colorado Department of Obstetrics & Gynecology, Aurora

06520

RECRUITING

Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

collaborator

Northwestern University

OTHER

collaborator

University of North Carolina

OTHER

collaborator

Duke University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Yale University

OTHER